ER, PR, HER2, Ki-67 and CK5 in Early and Late Relapsing Breast Cancer—Reduced CK5 Expression in Metastases

Breast cancer can recur even decades after the primary therapy. Markers are needed to predict cancer progression and the risk of late recurrence. The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), proliferation marker Ki-67, and cytokeratin CK5 w...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Joensuu, Kristiina, Leidenius, Marjut, Kero, Mia, Andersson, Leif C., Horwitz, Kathryn B., Heikkilä, Päivi
Format: Artigo
Langue:Inglês
Publié: Libertas Academica 2013
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579427/
https://ncbi.nlm.nih.gov/pubmed/23514931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/BCBCR.S10701
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires